Suppressing Adenosine and IDO, increasing the mitochondrial function and cytokine production using PCG1, as well as catalase expression to counteract TME hypoxic conditions by ACAT1 are examples of TME metabolic alterations contributing to cancer improvement. The gene discussed is IDO1; the disease is cancer.